Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston W Tan

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of General Internal Medicine|April 4, 2008
Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of lifeSusan G Coe, Winston W Tan, Thomas P Fox
Mayo Clinic Proceedings|March 14, 2007
The role of mammography in male patients with breast symptomsStephanie L Hines, Winston W Tan, Mona Yasrebi, et al.
BMC Cancer|May 13, 2008
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapyJohn M Pendleton, Winston W Tan, Satoshi Anai, et al.
Journal of Psychosocial Oncology|November 1, 2011
Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinomaSteven C Ames, Alex S Parker, Julia E Crook, et al.
Clinical Breast Cancer|January 18, 2016
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer PatientsWinston W Tan, Jacob B Allred, Alvaro Moreno-Aspitia, et al.
Investigational New Drugs|May 4, 2005
Phase II trial of dolastatin-10 in patients with advanced breast cancerEdith A Perez, David W Hillman, Paul A Fishkin, et al.
Cell Research|August 31, 2006
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumorSeakwoo Lee, Kevin K Desai, Kenneth A Iczkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinomaChristina A von Roemeling, Laura A Marlow, Johnny J Wei, et al.
Clinical Breast Cancer|March 27, 2012
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trialWinston W Tan, Jacob B Allred, Muhammad Salim, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of General Internal Medicine|April 4, 2008
Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of lifeSusan G Coe, Winston W Tan, Thomas P Fox
Mayo Clinic Proceedings|March 14, 2007
The role of mammography in male patients with breast symptomsStephanie L Hines, Winston W Tan, Mona Yasrebi, et al.
BMC Cancer|May 13, 2008
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapyJohn M Pendleton, Winston W Tan, Satoshi Anai, et al.
Journal of Psychosocial Oncology|November 1, 2011
Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinomaSteven C Ames, Alex S Parker, Julia E Crook, et al.
Clinical Breast Cancer|January 18, 2016
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer PatientsWinston W Tan, Jacob B Allred, Alvaro Moreno-Aspitia, et al.
Investigational New Drugs|May 4, 2005
Phase II trial of dolastatin-10 in patients with advanced breast cancerEdith A Perez, David W Hillman, Paul A Fishkin, et al.
Cell Research|August 31, 2006
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumorSeakwoo Lee, Kevin K Desai, Kenneth A Iczkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinomaChristina A von Roemeling, Laura A Marlow, Johnny J Wei, et al.
Clinical Breast Cancer|March 27, 2012
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trialWinston W Tan, Jacob B Allred, Muhammad Salim, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Pageof 3